-
2022-500905-42-00
3
2023-03-24
pancreatic ductal adenocarcinoma
-
2024-513269-37-00
6
2023-03-14
Migraine attacks with or without aura
-
2023-509783-23-00
4
2023-02-24
Diffuse Cutaneous Systemic Sclerosis
-
2023-510317-26-00
4
2023-02-07
Amyotrophic Lateral Sclerosis
-
2023-503793-20-00
5
2023-01-18
Prevention of ischemic stroke in patients post acute non-cardioembolic
-
2023-504239-41-00
5
2023-01-09
Hepatitis B, Chronic
-
2023-510195-31-00
4
2023-01-03
Idiopathic or Diabetic Gastroparesis
-
2024-514352-32-00
10
2023-01-03
Acute ischemic stroke
-
2022-500424-30-00
4
2022-12-28
Parkinson’s disease
-
2022-502078-17-00
4
2022-12-15
unresectable hepatocellular carcinoma
-
2024-513262-19-00
5
2022-11-21
Thrombotic Thrombocytopenic Purpura
-
2023-505904-41-00
5
2022-11-17
Hereditary Angioedema Type I or II
-
2024-513651-32-00
4
2022-11-10
Juvenile Dermatomyositis
-
2022-500628-31-00
4
2022-10-24
Advanced Melanoma
-
2024-516064-28-00
5
2022-09-27
Acute Graft Versus Host Disease
-
2023-505458-16-00
5
2022-09-13
Gastric and Gastroesophageal Junction Cancer With FGFR2b Overexpressio
-
2024-510729-24-00
6
2022-09-01
Chronic Migrane, Migrane, Medication Overuse Headache
-
2022-500363-12-00
4
2022-08-24
SARS CoV-2 (COVID-19)
-
2022-502773-41-00
9
2022-06-16
Relapsed/Refractory Classical Hodgkin Lymphoma
-
2024-514230-20-00
4
2022-06-08
Stroke
-
2024-511996-13-00
5
2022-05-11
Previously untreated, unresectable, or metastatic melanoma
-
2024-515090-96-00
11
2022-05-10
Thyroid Eye Disease
-
2024-513173-44-00
4
2022-05-03
Adults patients having non severe HLH
-
2022-502802-34-00
5
2022-04-05
Dravet and Lennox-Gastaut Syndromes